These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 1928043
1. Breast cancer-associated protein pS2 expression in tumors of the biliary tract. Seitz G, Thelsinger B, Tomasetto G, Rio MC, Chambon P, Blin N, Welter G. Am J Gastroenterol; 1991 Oct; 86(10):1491-4. PubMed ID: 1928043 [Abstract] [Full Text] [Related]
2. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Welter C, Theisinger B, Seitz G, Tomasetto C, Rio MC, Chambon P, Blin N. Lab Invest; 1992 Feb; 66(2):187-92. PubMed ID: 1735955 [Abstract] [Full Text] [Related]
3. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. Poulsom R, Hanby AM, Lalani EN, Hauser F, Hoffmann W, Stamp GW. J Pathol; 1997 Sep; 183(1):30-8. PubMed ID: 9370944 [Abstract] [Full Text] [Related]
4. Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumors. Welter C, Theisinger B, Rio MC, Seitz G, Schüder G, Blin N. Int J Cancer; 1994 Jan 02; 56(1):52-5. PubMed ID: 7505265 [Abstract] [Full Text] [Related]
5. Expression of the breast cancer-associated protein pS2 in adenosquamous carcinomas of the gastrointestinal tract. Welter C, Seitz G, Blin N. Acta Oncol; 1993 Jan 02; 32(3):315-7. PubMed ID: 8323770 [Abstract] [Full Text] [Related]
6. Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: delineation of epithelial phenotype. Hanby AM, Jankowski JA, Elia G, Poulsom R, Wright NA. J Pathol; 1994 Jul 02; 173(3):213-9. PubMed ID: 7931841 [Abstract] [Full Text] [Related]
7. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Theisinger B, Welter C, Seitz G, Rio MC, Lathe R, Chambon P, Blin N. Eur J Cancer; 1991 Jul 02; 27(6):770-3. PubMed ID: 1829922 [Abstract] [Full Text] [Related]
8. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. Gastroenterology; 1993 Oct 02; 105(4):1110-6. PubMed ID: 8405856 [Abstract] [Full Text] [Related]
9. Influence of steroid hormones on pS2/BCEI gene expression in xenografted colon tumors. Theisinger B, Guthke R, Blin N, Welter C, Seitz G. In Vivo; 1993 Oct 02; 7(5):411-4. PubMed ID: 8110982 [Abstract] [Full Text] [Related]
10. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors. Saegusa M, Hashimura M, Hara A, Okayasu I. J Pathol; 2000 Apr 02; 190(5):554-63. PubMed ID: 10727981 [Abstract] [Full Text] [Related]
11. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Rio MC, Chambon P. Cancer Cells; 1990 Apr 02; 2(8-9):269-74. PubMed ID: 2223388 [Abstract] [Full Text] [Related]
12. Detection of pS2 messenger RNA in gynecological cancers. Wysocki SJ, Hahnel E, Masters A, Smith V, McCartney AJ, Hahnel R. Cancer Res; 1990 Mar 15; 50(6):1800-2. PubMed ID: 2306733 [Abstract] [Full Text] [Related]
13. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns. Dookeran KA, Rye PD, Dearing SJ, Walker RA. J Pathol; 1993 Oct 15; 171(2):123-9. PubMed ID: 8283349 [Abstract] [Full Text] [Related]
14. Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts. Dante R, Ribieras S, Baldassini S, Martin V, Benzerara O, Bouteille C, Brémond A, Frappart L, Rio MC, Lasne Y. Lab Invest; 1994 Aug 15; 71(2):188-92. PubMed ID: 8078298 [Abstract] [Full Text] [Related]
15. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Daffada AA, Johnston SR, Smith IE, Detre S, King N, Dowsett M. Cancer Res; 1995 Jan 15; 55(2):288-93. PubMed ID: 7812959 [Abstract] [Full Text] [Related]
16. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. Tomasetto C, Rio MC, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R. EMBO J; 1990 Feb 15; 9(2):407-14. PubMed ID: 2303034 [Abstract] [Full Text] [Related]
17. Expression of the pS2 protein and correlation with estrogen receptor status in fine-needle aspirates from breast carcinomas. Sauer T, Naess O. Diagn Cytopathol; 1994 Feb 15; 11(2):165-7. PubMed ID: 7813365 [Abstract] [Full Text] [Related]
18. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. Wright NA, Poulsom R, Stamp GW, Hall PA, Jeffery RE, Longcroft JM, Rio MC, Tomasetto C, Chambon P. J Pathol; 1990 Dec 15; 162(4):279-84. PubMed ID: 2290113 [Abstract] [Full Text] [Related]
19. Expression of the pS2 gene in breast cancer--a comparison of pS2 protein radioimmunoassay and immunohistochemistry. Robbins PD, Hähnel E, Sterrett GF, Harvey J, Carrello S, Hähnel R. Pathology; 1993 Jul 15; 25(3):255-60. PubMed ID: 8265245 [Abstract] [Full Text] [Related]
20. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. Lefebvre O, Wolf C, Kédinger M, Chenard MP, Tomasetto C, Chambon P, Rio MC. J Cell Biol; 1993 Jul 15; 122(1):191-8. PubMed ID: 8314841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]